Back to database

Deal Detail

Thorne HealthTech, Inc. to The Procter & Gamble Company

EV / LTM EBITDA
-
EV / LTM Sales
5.6x
Enterprise Value
$3.8B
Primary Source
JPM research

Comparable Transactions

Consumer Health transactions announced in the five years to August 2026. 7 with a disclosed multiple.

DateTargetAcquirorEnterprise ValueEV/SalesEV/EBITDAType
Jun 2026yfood LabsNestlé S.A.$523M3.5x-Strategic
May 2026LaCorium HealthPrestige Consumer Healthcare$150M3.8x12.5xStrategic
Mar 2026Breath Right (and other brands)Prestige Consumer Healthcare$1.0B5.2x11.0xStrategic
Dec 2024Hiya Health Products, LLCUSANA Health Sciences, Inc.$260M2.5x11.8xStrategic
Aug 2023Thorne Healthtech, Inc.L Catterton$681M-21.2xFinancial
Apr 2023Blackmores LimitedKirin Holdings Company, Limited$1.2B-23.1xStrategic
Jun 2022Nutrawise Health & Beauty Corp.Jamieson Wellness Inc.$210M1.8x10.0xStrategic
Mean3.4x14.9x
Median3.5x12.2x

All Observations

Source-specific multiples and notes for this transaction.

CompPrimary?Source TypeSourceSource AdvisorSource YearEV (USD)EV/SalesEV/EBITDAEV/Fwd EBITDANoteCitation
PrimaryresearchJPM research-2026$3.8B5.6x---Open